Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

ANALYSIS OF DL--TOCOPHEROL AS ANTIOXIDANT ON MALONDIALDEHYDE LEVEL IN PEDIATRIC PATIENTS WITH -THALASSEMIA MAJOR

Folia Medica Indonesiana · Vol. 53 No. 1 (2017) · hlm. 49–49

DOI
10.20473/fmi.v53i1.5490
ISSN
2355-8393, 2599-056X
Terbit
2017-08-15
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Thalassemia is a hereditary form of anemia that affects the synthesis of hemoglobin. The management of therapy in patients with b-thalassemia major which patients should receive continuous blood transfusions and increased iron absorption from the digestive tract causes excess iron in the body. This will lead to an increase of free iron level that triggers Radical Oxygen Species (ROS). Increased level of ROS can initiate lipid peroxidation which used as an indicator of oxidative stress in cells and tissues and produce reactive carbonyl, mainly malondialdehyde (MDA). Thus, MDA measurement is widely used as an indicator of lipid peroxidation. On the other hand, the risk of oxidative damage can be reduced by antioxidant, one of them is Vitamin E that is a fat-soluble vitamin with high potential antioxidant. The objective of this study was to analyze the effect of the dl-a-tocopherol (Vitamin E) administration on decrease of MDA serum level on pediatric patients with b-thalassemia major. This was a longitudinal observational study design for one group without comparison was conducted to examine the use of vitamin E to decreased MDA serum level on children patients with b-thalassemia major. The inclusion criteria were patients who rely on blood transfusions, patients who received only one type of iron chelating agents during the study period, the clinical condition is stable, agrees, and has completed the informed consent. In the course of the study of 21 patients there were variations in patient compliance in taking vitamin E tablet dosage 200 IU once-daily for one month: only 11 out of 21 patients consumed 30 tablets of vitamin E 200 IU (total dose of 6000 IU) in the 1-month study, and only data from those 11 samples will be analysed further. MDA serum level was measured pre- and post-administration of vitamin E and patient’s characteristics of subjects was obtained for additional information. Pre-administration of vitamin E, serum level of MDA was 1239.4 ± 502.55 ng/mL with a range of 216.95 to 2297.3 ng/mL, whereas in the group post administration of vitamin E, MDA serum level was 786.49 ± 704.88 ng/mL with a range of 6.5380 to 1958.6 ng/mL. In conclusion, there was no significant difference in MDA serum level in the group pre- and post- administration of vitamin E (p = 0.15).

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 84 tautan kepenulisan bersama · 29 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • RSUD Prof. Dr. Saiful Anwar Malang
  • University of Brawijaya
  • State University of Semarang
  • Rumah Sakit Umum Haji Surabaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
I Dewa Gede UgrasenaUniversitas Airlangga3
Siti MuafifahState University of Semarang2
Didik HasmonoUniversitas Airlangga2
Nun ZairinaRumah Sakit Dokter Soetomo2
Octaviana Maria SimbolonUniversitas Airlangga2
I Dg UgrasenaUniversitas Airlangga2
Bambang PermonoRumah Sakit Dokter Soetomo2
Dessy Surya SetyaniUniversitas Airlangga2
Audylia HartonoUniversitas Airlangga1
Andi CahyadiUniversitas Airlangga1
Maria Christina Shanty LarasatiAfiliasi tidak diketahui1
Almeir Pradhipta Andras AsmaraAfiliasi tidak diketahui1
Binti MuzayyanahUniversitas Airlangga1
Nuraida WisudaniAfiliasi tidak diketahui1
Eddy Zarkaty MRumah Sakit Umum Haji Surabaya1
Teri Wina HerwatiUniversitas Airlangga1
Budi SupraptiUniversitas Airlangga1
Mida PurwiningtyasUniversitas Airlangga1
Bayu Dharma SantiAfiliasi tidak diketahui1
Desantika WuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Bagus Putu Putra SuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Soedarsono SoedarsonoRumah Sakit Dokter Soetomo1
Herni SetyawatiUniversitas Airlangga1
Umi FatmawatiRumah Sakit Dokter Soetomo1
Febriansyah Nur UtomoRumah Sakit Dokter Soetomo1
Nur OktaviaUniversitas Airlangga1
Unedo Hence Markus SihombingAfiliasi tidak diketahui1
Hendriette Irene MamoUniversitas Airlangga1
Darto SaharsoRumah Sakit Dokter Soetomo1
Melawati OlevianingrumAfiliasi tidak diketahui1
Susanto NugrohoUniversity of Brawijaya1
Sri WinarsihRSUD Prof. Dr. Saiful Anwar Malang1
Reta Anggraeni WidyaUniversitas Airlangga1
Suharjono SuharjonoUniversity of Brawijaya1
Ekanita DesianiUniversitas Airlangga1
Dwi Hari SusiloUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">ANALYSIS OF DL--TOCOPHEROL AS ANTIOXIDANT ON MALONDIALDEHYDE LEVEL IN PEDIATRIC PATIENTS WITH -THALASSEMIA MAJOR</dc:title><dc:creator>Levana Rismayanti</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>Mia Ratwita Andarsini</dc:creator><dc:creator>Mariyatul Qibtiyah</dc:creator><dc:subject>beta-thalassemia major</dc:subject><dc:subject>vitamin E</dc:subject><dc:subject>alpha-tocopherol</dc:subject><dc:subject>malondialdehyde</dc:subject><dc:subject>lipid peroxidation</dc:subject><dc:subject>oxidative stress</dc:subject><dc:subject>antioxidant supplementation</dc:subject><dc:subject>pediatric patients</dc:subject><dc:subject>iron overload</dc:subject><dc:subject>blood transfusion</dc:subject><dc:subject>iron chelation</dc:subject><dc:subject>medication adherence</dc:subject><dc:subject>hemoglobin synthesis disorders</dc:subject><dc:subject>reactive oxygen species</dc:subject><dc:description xml:lang="en">Thalassemia is a hereditary form of anemia that affects the synthesis of hemoglobin. The management of therapy in patients with b-thalassemia major which patients should receive continuous blood transfusions and increased iron absorption from the digestive tract causes excess iron in the body. This will lead to an increase of free iron level that triggers Radical Oxygen Species (ROS). Increased level of ROS can initiate lipid peroxidation which used as an indicator of oxidative stress in cells and tissues and produce reactive carbonyl, mainly malondialdehyde (MDA). Thus, MDA measurement is widely used as an indicator of lipid peroxidation. On the other hand, the risk of oxidative damage can be reduced by antioxidant, one of them is Vitamin E that is a fat-soluble vitamin with high potential antioxidant. The objective of this study was to analyze the effect of the dl-a-tocopherol (Vitamin E) administration on decrease of MDA serum level on pediatric patients with b-thalassemia major. This was a longitudinal observational study design for one group without comparison was conducted to examine the use of vitamin E to decreased MDA serum level on children patients with b-thalassemia major. The inclusion criteria were patients who rely on blood transfusions, patients who received only one type of iron chelating agents during the study period, the clinical condition is stable, agrees, and has completed the informed consent. In the course of the study of 21 patients there were variations in patient compliance in taking vitamin E tablet dosage 200 IU once-daily for one month: only 11 out of 21 patients consumed 30 tablets of vitamin E 200 IU (total dose of 6000 IU) in the 1-month study, and only data from those 11 samples will be analysed further. MDA serum level was measured pre- and post-administration of vitamin E and patient’s characteristics of subjects was obtained for additional information. Pre-administration of vitamin E, serum level of MDA was 1239.4 ± 502.55 ng/mL with a range of 216.95 to 2297.3 ng/mL, whereas in the group post administration of vitamin E, MDA serum level was 786.49 ± 704.88 ng/mL with a range of 6.5380 to 1958.6 ng/mL. In conclusion, there was no significant difference in MDA serum level in the group pre- and post- administration of vitamin E (p = 0.15).</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-15</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v53i1.5490</dc:identifier><dc:identifier>10.20473/fmi.v53i1.5490</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 53 No 1 (2017); 49-49</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5490/3385</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>